CANO FRANCIS 4

What Happened
Director Francis Cano reported dispositions on 2026-02-10 tied to the completed Sanofi merger. The filing shows he disposed of a total of 188,663 shares (several entries are marked as derivative settlements). The transactions were made to the issuer pursuant to the Merger Agreement, which paid $15.50 per outstanding common share. If all disposed items were treated as full-share cash-outs, that implies gross proceeds of about $2.92 million; however, RSUs were paid at $15.50 per share while stock options were cashed out for the spread (Offer Price minus exercise price), so the actual cash received may differ.

Key Details

• Transaction date: 2026-02-10 (Effective Time of the merger).
• Reported dispositions: 188,663 total shares across multiple entries (individual entries listed in the Form 4).
• Reported price reference: Offer Price $15.50 per share (paid in cash under the Merger Agreement).
• Total implied value (if all were full-share payouts): ~ $2,924,276.50. Actual payout differs for options (only the spread was paid) per footnotes.
• Derivative treatment: Footnote F3 — RSUs cancelled and converted into right to receive cash equal to the number of shares underlying the RSUs × $15.50. Footnote F4 — outstanding options were vested immediately prior to the Effective Time and cancelled for cash equal to (shares × (Offer Price − exercise price)).
• Shares owned after transaction: not specified on the Form 4; the transactions relate to the merger cash-out and tender/merger process that extinguished or converted outstanding public common shares.
• Timeliness: Filing reports the transaction and Effective Time as 2026-02-10; no late filing is indicated.

Context
These were not open‑market sales but cash settlements required by the Merger Agreement with Sanofi (tender/merger consideration). That means the dispositions reflect the corporate transaction mechanics (RSU cancellation and option cash-outs), not necessarily a conventional insider "sell" as a statement on future company prospects. For options specifically, the filing notes they vested immediately prior to the merger and were converted into a cash payment equal to the spread (Offer Price − exercise price).